moxifloxacin has been researched along with Keratitis in 50 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 11 (22.00) | 29.6817 |
| 2010's | 24 (48.00) | 24.3611 |
| 2020's | 15 (30.00) | 2.80 |
| Authors | Studies |
|---|---|
| Beuerman, RW; Chalasani, MLS; Iyer, A; Lakshminarayanan, R; Leng Goh, ET; Lloyd, DG; Madder, A; Mayandi, V; Parmar, A; Prior, SH; Singh, I; Taylor, EJ; Verma, NK | 1 |
| Agrawal, R; Barathi, VA; Beuerman, RW; Chan, LW; Jie, TY; Koh, SK; Lakshminarayanan, R; Leng, ET; Mayandi, V; Sebastian, TM; Somaraju Chalasani, ML; Ting, DSJ; Urf Turabe Fazil, MH; Varadarajan, J; Verma, NK; Xi, Q; Zhou, L | 1 |
| Aragona, P; Biondo, C; Inferrera, L; Postorino, EI; Roszkowska, AM; Severo, AA | 1 |
| Cevallos, AV; Keenan, JD; Lee, MD; Lin, YB; Oji, NM; Seitzman, GD | 1 |
| Bhatt, H; Biswas, S; Ch, S; Ghosh, B; Mishra, P; Roy, S | 1 |
| Das, S; Gunasekaran, R; Mitra, S; Mohamed, A; Prajna, L; Prajna, NV; Sharma, S; Soni, T | 1 |
| Bhamare, P; Dunman, PM; Johnson, W; Kinn, B; Laskey, E; Mei, JA; Nolin, L; Stalker, C; Wozniak, RAF | 1 |
| Kesavan, K; Mohan, P; Rangari, VD | 1 |
| Baratz, KH; Farazdaghi, MK; Patel, SV; Tailor, PD | 1 |
| Biswas, S; Ch, S; Ghosh, B; Padaga, SG; Roy, S | 1 |
| Malani, M; Nirmal, J; Saha, S; Thodikayil, AT | 1 |
| Mansoori, T; Reddy, AK; Sistla, A; Srirampur, A; Suresh, N | 1 |
| Das, S; Sahoo, S | 1 |
| Chhabria, M; Kudaravalli, P; Lesho, E; Pendela, VS | 1 |
| Bramblett, GT; Eriksson, E; Griffith, GL; Johnson, AJ; McDaniel, JS; Rebeles, J; Scott, LLF | 1 |
| Kesavan, K; Mohan, P | 1 |
| Kim, EK; Kim, SK; Kim, TI; Ko, J; Yong, DE | 1 |
| Arguello, RA; Chevez-Barrios, P; Divatia, MK; Matoba, AY | 1 |
| Kim, KH; Kim, MJ; Kim, S; Le, VH; Lee, JA; Lee, JH; Lee, S; Park, JH; Tchah, H | 1 |
| Galvis, V; Gómez, MA; Grice, JM; Niño, CA; Tello, A | 1 |
| Chojnacki, M; Dunman, PM; Philbrick, A; Reed, JN; Tomaras, A; Wozniak, RAF; Wucher, B | 1 |
| Chandrika, TN; Katta, KR; Mansoori, T; Reddy, AK; Srirampur, A | 1 |
| Acharya, NR; Glidden, DV; Lietman, TM; Mascarenhas, J; McLeod, SD; Oldenburg, CE; Rajaraman, R; Ravindran, M; Ray, KJ; Srinivasan, M; Sun, CQ; Zegans, ME | 1 |
| Fariña, N; Franco, A; Giusiano, G; Laspina, F; Mino de Kaspar, H; Samudio, M | 1 |
| Ambati, BK; Archer, B; Cho, YK; Das, SK; Uehara, H | 1 |
| Fulcher, LC; Johnson, D; Jorgensen, J; Kiel, JW; McElmeel, ML; Montes, JA | 1 |
| Bisignano, G; Blanco, AR; Ginestra, G; Marino, A; Nostro, A | 1 |
| Eguchi, H; Hotta, F; Ishimaru, M; Kogiso, M; Kusaka, S; Nishimura, K; Shimomura, Y; Yaguchi, T | 1 |
| Barrett, R; Lehmann, AE; Matoba, AY | 1 |
| Scoper, SV | 1 |
| Farley, SJ; Mack, RJ; Schatz, S; Shott, S | 1 |
| Callegan, MC; Moyer, AL; Novosad, BD; Ramadan, RT; Wiskur, B | 1 |
| Jain, V; Natarajan, S; Sajnani, M; Shome, D | 1 |
| Akova, YA; Altinors, DD; Bayar, SA; Kucukerdonmez, C | 1 |
| King, LB; Marquart, ME; Norcross, EW; Sanders, ME; Taylor, SD; Tolo, I; Tullos, NA | 1 |
| Cox, SK; Hendrix, DV; Ward, DA; Westermeyer, HD | 1 |
| Kim, HJ; Seo, JW; Son, SW | 1 |
| Ahmed, AA; Pineda, R | 1 |
| El-Adly, AA; El-Laithy, HM; Nesseem, DI; Shoukry, M | 1 |
| Carelli, R; Forte, R; Magli, A; Rombetto, L | 1 |
| Galvis, V; Rey, JJ; Tello, A; Villareal, D; Wong, CA | 1 |
| Fernandes, M; Mittal, V | 1 |
| Dajcs, JJ; Girgis, DO; Marquart, ME; O'Callaghan, RJ; Thibodeaux, BA; Traidej, M | 1 |
| Caballero, AR; Dajcs, JJ; Girgis, DO; Marquart, ME; O'Callaghan, RJ; Thibodeaux, BA | 1 |
| Aliprandis, E; Ciralsky, J; Herling, I; Katz, HR; Lai, H | 1 |
| Gonzalez-Fernandez, F; Patel, NR; Reidy, JJ | 1 |
| Tyler, ME; Walter, K | 1 |
| Choi, HW; Chung, SH; Moon, SW; Nam, KH | 1 |
| Inoue, T; Kida, T; Naka, H; Sakaki, H; Tokushige, H; Wada, T | 1 |
| Andreo, EG; Arcieri, ES; Arcieri, RS; Finotti, IG; Furlanetto, RL; Mendonça, CN; Rizzo, LV; Rocha, A; Rocha, FJ | 1 |
7 review(s) available for moxifloxacin and Keratitis
| Article | Year |
|---|---|
Combined Phialemonium curvatum and Acanthamoeba Keratitis: The Importance of Early Diagnosis and Specific Therapy.
Topics: Acanthamoeba Keratitis; Administration, Ophthalmic; Anti-Bacterial Agents; Antifungal Agents; Ascomycota; Biguanides; Disinfectants; Drug Therapy, Combination; Early Diagnosis; Eye Infections, Fungal; Female; Humans; Keratitis; Microscopy, Confocal; Middle Aged; Moxifloxacin; Mycoses; Ophthalmic Solutions; Slit Lamp Microscopy; Voriconazole | 2021 |
Delayed onset Mycobacterium intracellulare keratitis after laser in situ keratomileusis: A case report and literature review.
Topics: Administration, Topical; Adult; Amikacin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Eye Infections, Bacterial; Fluoroquinolones; Follow-Up Studies; Humans; Keratitis; Keratomileusis, Laser In Situ; Male; Moxifloxacin; Mycobacterium avium Complex; Severity of Illness Index; Treatment Outcome | 2017 |
Topical insulin in neurotrophic keratopathy after resection of acoustic neuroma.
Topics: Administration, Ophthalmic; Anti-Bacterial Agents; Combined Modality Therapy; Contact Lenses, Hydrophilic; Corneal Ulcer; Facial Nerve Injuries; Facial Paralysis; Female; Humans; Insulin; Keratitis; Middle Aged; Moxifloxacin; Neuroma, Acoustic; Postoperative Complications; Staphylococcal Infections; Trigeminal Nerve Injuries; Vancomycin | 2019 |
[Keratitis by Lasiodiplodia theobromae: a case report and literature review].
Topics: Ascomycota; Eye Infections, Fungal; Fluconazole; Fluoroquinolones; Humans; Keratitis; Male; Middle Aged; Moxifloxacin | 2014 |
Review of third-and fourth-generation fluoroquinolones in ophthalmology: in-vitro and in-vivo efficacy.
Topics: Administration, Topical; Anti-Bacterial Agents; Aza Compounds; Endophthalmitis; Fluoroquinolones; Gatifloxacin; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Keratitis; Levofloxacin; Microbial Sensitivity Tests; Moxifloxacin; Ofloxacin; Ophthalmology; Quinolines | 2008 |
Alcaligenes xylosoxidans contact lens-related keratitis--a case report and literature review.
Topics: Adult; Alcaligenes; Anti-Bacterial Agents; Aza Compounds; Conjunctiva; Contact Lenses; Cornea; Fluoroquinolones; Gram-Negative Bacterial Infections; Humans; Keratitis; Male; Moxifloxacin; Quinolines | 2011 |
Nocardia keratitis after laser in situ keratomileusis: clinicopathologic correlation.
Topics: Administration, Topical; Anti-Bacterial Agents; Aza Compounds; Drug Therapy, Combination; Female; Fluoroquinolones; Humans; Imipenem; Keratitis; Keratomileusis, Laser In Situ; Keratoplasty, Penetrating; Middle Aged; Moxifloxacin; Necrosis; Nocardia asteroides; Nocardia Infections; Quinolines; Recurrence | 2005 |
1 trial(s) available for moxifloxacin and Keratitis
| Article | Year |
|---|---|
Early addition of topical corticosteroids in the treatment of bacterial keratitis.
Topics: Administration, Topical; Adult; Aza Compounds; Confidence Intervals; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Eye Infections, Bacterial; Female; Fluoroquinolones; Follow-Up Studies; Humans; Keratitis; Linear Models; Male; Middle Aged; Moxifloxacin; Multivariate Analysis; Prednisolone; Quinolines; Severity of Illness Index; Time Factors; Treatment Outcome | 2014 |
42 other study(ies) available for moxifloxacin and Keratitis
| Article | Year |
|---|---|
Design and Syntheses of Highly Potent Teixobactin Analogues against Staphylococcus aureus, Methicillin-Resistant Staphylococcus aureus (MRSA), and Vancomycin-Resistant Enterococci (VRE) in Vitro and in Vivo.
Topics: Animals; Depsipeptides; Drug Design; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Keratitis; Methicillin-Resistant Staphylococcus aureus; Mice; Staphylococcal Infections; Staphylococcus aureus; Vancomycin Resistance; Vancomycin-Resistant Enterococci | 2018 |
Rational Substitution of ε-Lysine for α-Lysine Enhances the Cell and Membrane Selectivity of Pore-Forming Melittin.
Topics: Amino Acid Sequence; Amino Acid Substitution; Animals; Anti-Bacterial Agents; Antifungal Agents; Bacteria; Bees; Candida albicans; Cell Membrane; Cornea; Eye Infections, Bacterial; Female; Humans; Keratitis; Lysine; Melitten; Mice, Inbred C57BL; Microbial Sensitivity Tests; Proof of Concept Study; Rabbits; Unilamellar Liposomes | 2020 |
Assessment of Antimicrobial Activity of Dehydrated Amniotic Membrane in Infectious Keratitis: A Small Retrospective Case Series and In Vitro Study.
Topics: Acanthamoeba castellanii; Acanthamoeba Keratitis; Adolescent; Adult; Amnion; Anti-Bacterial Agents; Eye Infections, Bacterial; Humans; Keratitis; Male; Microbial Sensitivity Tests; Middle Aged; Moxifloxacin; Pseudomonas aeruginosa; Pseudomonas Infections; Retrospective Studies; Staphylococcal Infections; Staphylococcus aureus; Streptococcal Infections; Streptococcus pneumoniae | 2021 |
Hydroxypropyl methacrylamide-based copolymeric nanoparticles loaded with moxifloxacin as a mucoadhesive, cornea-penetrating nanomedicine eye drop with enhanced therapeutic benefits in bacterial keratitis.
Topics: Acrylamides; Cornea; Humans; Keratitis; Moxifloxacin; Nanomedicine; Nanoparticles; Ophthalmic Solutions; Polymers; Staphylococcus aureus | 2021 |
Corynebacterium Keratitis: Pure Versus Mixed Infection and Antibiotic Susceptibility Patterns From Different Tertiary Eye Care Centers.
Topics: Anti-Bacterial Agents; Cefazolin; Ciprofloxacin; Coinfection; Corynebacterium; Eye Infections, Bacterial; Fluoroquinolones; Gatifloxacin; Humans; Keratitis; Microbial Sensitivity Tests; Moxifloxacin; Ofloxacin; Retrospective Studies; Tertiary Care Centers; Vancomycin | 2022 |
Antimicrobial Activity of a Triple Antibiotic Combination Toward Ocular Pseudomonas aeruginosa Clinical Isolates.
Topics: Anti-Bacterial Agents; Bacitracin; Drug Combinations; Erythromycin; Framycetin; Humans; Keratitis; Levofloxacin; Moxifloxacin; Polymyxin B; Pseudomonas aeruginosa; Pseudomonas Infections; Rifampin; Tobramycin; Trimethoprim | 2022 |
Cationic Chitosan/Pectin Polyelectrolyte Nanocapsules of Moxifloxacin as Novel Topical Management System for Bacterial Keratitis.
Topics: Animals; Anti-Bacterial Agents; Chitosan; Cornea; Delayed-Action Preparations; Fluoroquinolones; Keratitis; Moxifloxacin; Nanocapsules; Particle Size; Pectins; Polyelectrolytes; Rabbits | 2022 |
Oleander-Associated Keratitis and Uveitis.
Topics: Corneal Edema; Cyclopentolate; Female; Humans; Inflammation; Keratitis; Middle Aged; Moxifloxacin; Nerium; Prednisolone; Prednisone; Uveitis, Anterior | 2022 |
Chitosan-poly(lactide-co-glycolide)/poloxamer mixed micelles as a mucoadhesive thermo-responsive moxifloxacin eye drop to improve treatment efficacy in bacterial keratitis.
Topics: Animals; Anti-Bacterial Agents; Chitosan; Humans; Keratitis; Mice; Micelles; Moxifloxacin; Ophthalmic Solutions; Poloxamer; Polyglactin 910; Staphylococcus aureus; Treatment Outcome | 2023 |
Carboxylated nanofibrillated cellulose empowers moxifloxacin to overcome Staphylococcus aureus biofilm in bacterial keratitis.
Topics: Anti-Bacterial Agents; Bacteria; Biofilms; Cellulose; Cornea; Eye Infections, Bacterial; Humans; Keratitis; Microbial Sensitivity Tests; Moxifloxacin; Staphylococcal Infections; Staphylococcus aureus | 2024 |
Retrocorneal abscess: an unusual presentation of Nocardia keratitis after Descemet's stripping endothelial keratoplasty.
Topics: Abscess; Aged, 80 and over; Anti-Bacterial Agents; Antihypertensive Agents; Atropine; Corneal Diseases; Descemet Stripping Endothelial Keratoplasty; Eye Infections, Bacterial; Female; Humans; Keratitis; Microbial Sensitivity Tests; Moxifloxacin; Mydriatics; Nocardia; Nocardia Infections; Postoperative Complications; Slit Lamp Microscopy; Tomography, Optical Coherence; Visual Acuity | 2020 |
The "stung" cornea - Retained insect sting on the corneal endothelium.
Topics: Administration, Ophthalmic; Adult; Anti-Bacterial Agents; Corneal Injuries; Endothelium, Corneal; Eye Foreign Bodies; Glucocorticoids; Humans; Insect Bites and Stings; Keratitis; Male; Moxifloxacin; Prednisolone; Slit Lamp Microscopy | 2020 |
Case Report: A Polymicrobial Vision-Threatening Eye Infection Associated with Polysubstance Abuse.
Topics: Administration, Ophthalmic; Adult; Anti-Inflammatory Agents; Antioxidants; Ascorbic Acid; Ceftazidime; Cocaine; Cocaine-Related Disorders; Coinfection; Dopamine Uptake Inhibitors; Doxycycline; Endophthalmitis; Female; Gram-Positive Bacterial Infections; Humans; Keratitis; Kingella; Linezolid; Moxifloxacin; Neisseriaceae Infections; Ophthalmic Solutions; Prednisone; Propionibacterium acnes; Streptococcal Infections; Streptococcus; Substance Abuse, Intravenous; Tobramycin; Vancomycin; Voriconazole | 2020 |
Treatment of Corneal Infections Utilizing an Ocular Wound Chamber.
Topics: Animals; Eye Infections, Bacterial; Eye Injuries; Guinea Pigs; Keratitis; Moxifloxacin; Pseudomonas aeruginosa | 2020 |
Cationic Polyelectrolyte Nanocapsules of Moxifloxacin for Microbial Keratitis Therapy: Development, Characterization, and Pharmacodynamic Study.
Topics: Animals; Anti-Bacterial Agents; Chick Embryo; Cornea; Drug Development; Goats; Keratitis; Moxifloxacin; Nanocapsules; Polyelectrolytes; Rabbits | 2021 |
Clinically Significant Enhancement of Voriconazole Efficacy by Moxifloxacin and Gentamicin in Fungal Keratitis.
Topics: Anti-Bacterial Agents; Antifungal Agents; Drug Therapy, Combination; Eye Infections, Fungal; Fluoroquinolones; Gentamicins; Humans; Keratitis; Male; Middle Aged; Moxifloxacin; Treatment Outcome; Voriconazole; Young Adult | 2018 |
Two-photon microscopy of fungal keratitis-affected rabbit cornea ex vivo using moxifloxacin as a labeling agent.
Topics: Animals; Aspergillosis; Candidiasis; Diagnostic Techniques, Ophthalmological; Disease Models, Animal; Eye Infections, Fungal; Imaging, Three-Dimensional; Keratitis; Microscopy, Confocal; Microscopy, Fluorescence; Moxifloxacin; Rabbits; Staining and Labeling | 2018 |
Development of a Broad-Spectrum Antimicrobial Combination for the Treatment of Staphylococcus aureus and Pseudomonas aeruginosa Corneal Infections.
Topics: Animals; Anti-Bacterial Agents; Cornea; Disease Models, Animal; Drug Resistance, Multiple, Bacterial; Drug Synergism; Drug Therapy, Combination; Eye Infections, Bacterial; Female; Humans; Keratitis; Mice; Mice, Inbred BALB C; Moxifloxacin; Ophthalmic Solutions; Polymyxin B; Pseudomonas aeruginosa; Pseudomonas Infections; Rifampin; Staphylococcal Infections; Staphylococcus aureus; Treatment Outcome; Trimethoprim | 2019 |
Management of Nocardia Interface Keratitis After Descemet Membrane Endothelial Keratoplasty.
Topics: Administration, Ophthalmic; Aged; Anti-Bacterial Agents; Atropine; Ciprofloxacin; Combined Modality Therapy; Descemet Stripping Endothelial Keratoplasty; Drug Therapy, Combination; Eye Infections, Bacterial; Humans; Keratitis; Male; Moxifloxacin; Nocardia asteroides; Nocardia Infections; Ophthalmic Solutions; Reoperation; Retrospective Studies; Visual Acuity | 2019 |
Comparison of the Anti-angiogenic and Anti-inflammatory Effects of Two Antibiotics: Clarithromycin Versus Moxifloxacin.
Topics: Animals; Anti-Bacterial Agents; Clarithromycin; Cornea; Corneal Neovascularization; Disease Models, Animal; Dose-Response Relationship, Drug; Female; Fluoroquinolones; Immunohistochemistry; Keratitis; Mice; Mice, Inbred BALB C; Microscopy, Fluorescence; Moxifloxacin | 2016 |
Potency and Sterility of Fortified Tobramycin, Fortified Vancomycin, and Moxifloxacin at 4, 24, and 35°C for 14 Days.
Topics: Anti-Bacterial Agents; Drug Stability; Drug Storage; Eye Infections, Bacterial; Fluoroquinolones; Follow-Up Studies; Humans; Infertility; Keratitis; Microbial Sensitivity Tests; Moxifloxacin; Ophthalmic Solutions; Prospective Studies; Temperature; Time Factors; Tobramycin; Vancomycin | 2016 |
Ex vivo efficacy of gemifloxacin in experimental keratitis induced by methicillin-resistant Staphylococcus aureus.
Topics: Animals; Anti-Bacterial Agents; Bacterial Load; Colony Count, Microbial; Fluoroquinolones; Gemifloxacin; Keratitis; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Models, Theoretical; Moxifloxacin; Naphthyridines; Rabbits; Staphylococcal Infections; Treatment Outcome | 2016 |
A super-infection in the cornea caused by Stemphylium, Acremonium, and α-Streptococcus.
Topics: Acremonium; Aged; Anti-Infective Agents; Cefmenoxime; Coinfection; Cornea; Eye Infections, Fungal; Female; Fluoroquinolones; Humans; Keratitis; Levofloxacin; Moxifloxacin; Saccharomycetales; Streptococcus | 2017 |
Cure Rate of Fungal Keratitis With Antibacterial Therapy.
Topics: Adult; Anti-Bacterial Agents; Corneal Ulcer; Eye Infections, Fungal; Female; Fluoroquinolones; Humans; Keratitis; Male; Middle Aged; Moxifloxacin | 2017 |
Association between moxifloxacin ophthalmic solution and fungal infection in patients with corneal ulcers and microbial keratitis.
Topics: Adult; Anti-Infective Agents; Aza Compounds; Corneal Ulcer; Drug Contamination; Eye Infections, Bacterial; Eye Infections, Fungal; Female; Fluoroquinolones; Humans; Keratitis; Male; Moxifloxacin; Ophthalmic Solutions; Quinolines | 2009 |
Rate of bacterial eradication by ophthalmic solutions of fourth-generation fluoroquinolones.
Topics: Anti-Infective Agents; Aza Compounds; Benzalkonium Compounds; Colony Count, Microbial; Drug Evaluation, Preclinical; Drug Resistance, Bacterial; Endophthalmitis; Eye Infections, Bacterial; Fluoroquinolones; Gatifloxacin; Haemophilus influenzae; Humans; Keratitis; Moxifloxacin; Ophthalmic Solutions; Postoperative Complications; Preservatives, Pharmaceutical; Quinolines; Staphylococcus aureus; Staphylococcus epidermidis; Streptococcus pneumoniae; Time Factors | 2009 |
Fungal keratitis associated with ocular rosacea.
Topics: Adult; Aspergillosis; Aspergillus flavus; Aza Compounds; Doxycycline; Eye Infections, Fungal; Female; Fluoroquinolones; Humans; Keratitis; Male; Middle Aged; Moxifloxacin; Photophobia; Quinolines; Rosacea; Visual Acuity; Young Adult | 2010 |
Severe corneal changes following intravitreal injection of bevacizumab.
Topics: Aged; Aged, 80 and over; Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Aza Compounds; Bevacizumab; Choroidal Neovascularization; Corneal Edema; Descemet Membrane; Dexamethasone; Female; Fluoroquinolones; Humans; Keratitis; Macular Degeneration; Male; Moxifloxacin; Prednisolone; Quinolines; Retrospective Studies; Visual Acuity | 2010 |
Moxifloxacin and cholesterol combined treatment of pneumococcal keratitis.
Topics: Animals; Anti-Infective Agents; Aza Compounds; Cholesterol; Disease Models, Animal; Drug Therapy, Combination; Fluoroquinolones; Keratitis; Moxifloxacin; Peroxidase; Quinolines; Rabbits; Severity of Illness Index; Stem Cells; Streptococcus pneumoniae; Treatment Outcome | 2010 |
Tear, cornea, and aqueous humor concentrations of ciprofloxacin and moxifloxacin after topical ocular application in ophthalmologically normal horses.
Topics: Administration, Topical; Animals; Anti-Bacterial Agents; Aqueous Humor; Aza Compounds; Ciprofloxacin; Cornea; Fluoroquinolones; Horse Diseases; Horses; Keratitis; Moxifloxacin; Quinolines; Tears | 2011 |
A case of Stenotrophomonas maltophilia keratitis effectively treated with moxifloxacin.
Topics: Aged; Anti-Infective Agents; Aza Compounds; Cornea; Diagnosis, Differential; Eye Infections, Bacterial; Fluoroquinolones; Follow-Up Studies; Gram-Negative Bacterial Infections; Humans; Keratitis; Male; Moxifloxacin; Ophthalmic Solutions; Quinolines; Stenotrophomonas maltophilia; Visual Acuity | 2011 |
Moxifloxacin-Gelrite in situ ophthalmic gelling system against photodynamic therapy for treatment of bacterial corneal inflammation.
Topics: Adhesiveness; Animals; Anti-Bacterial Agents; Aqueous Humor; Area Under Curve; Aza Compounds; Bacterial Infections; Bacterial Load; Chemistry, Pharmaceutical; Cornea; Corneal Diseases; Escherichia coli; Excipients; Fluoroquinolones; Gels; Keratitis; Light; Male; Microbial Sensitivity Tests; Moxifloxacin; Mucous Membrane; Ophthalmic Solutions; Osmotic Pressure; Photochemotherapy; Polysaccharides, Bacterial; Quinolines; Rabbits; Reference Standards; Spectrometry, Fluorescence; Staphylococcus aureus; Viscosity | 2011 |
Bilateral methicillin-resistant Staphylococcus aureus keratitis following hyperopic photorefractive surgery.
Topics: Anti-Infective Agents; Antitubercular Agents; Aza Compounds; Diagnosis, Differential; Dose-Response Relationship, Drug; Female; Fluoroquinolones; Follow-Up Studies; Humans; Hyperopia; Keratitis; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Moxifloxacin; Netilmicin; Ophthalmic Solutions; Photorefractive Keratectomy; Quinolines; Staphylococcal Infections; Visual Acuity | 2012 |
[In vitro antibiotic susceptibility to fluoroquinolones].
Topics: Acanthamoeba Keratitis; Anti-Bacterial Agents; Aza Compounds; Body Fluids; Ciprofloxacin; Colombia; Conjunctivitis, Bacterial; Drug Resistance, Multiple, Bacterial; Eye Infections, Bacterial; Eye Infections, Fungal; Eye Infections, Parasitic; Fluoroquinolones; Gatifloxacin; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Keratitis; Levofloxacin; Microbial Sensitivity Tests; Moxifloxacin; Ofloxacin; Quinolines; Retrospective Studies | 2012 |
Cotrimoxazole-resistant Nocardia sclerokeratitis: effective therapy with fourth-generation fluoroquinolones.
Topics: Administration, Oral; Administration, Topical; Aged; Anti-Bacterial Agents; Aza Compounds; Drug Resistance, Bacterial; Drug Therapy, Combination; Eye Infections, Bacterial; Female; Fluoroquinolones; Gatifloxacin; Humans; Keratitis; Microbial Sensitivity Tests; Moxifloxacin; Nocardia; Nocardia Infections; Quinolines; Scleritis; Trimethoprim, Sulfamethoxazole Drug Combination | 2012 |
Effectiveness of ciprofloxacin, levofloxacin, or moxifloxacin for treatment of experimental Staphylococcus aureus keratitis.
Topics: Animals; Anti-Infective Agents; Aza Compounds; Ciprofloxacin; Cornea; Drug Resistance, Bacterial; Fluoroquinolones; Keratitis; Levofloxacin; Moxifloxacin; Ofloxacin; Quinolines; Rabbits; Staphylococcal Infections | 2004 |
Quantitative comparison of fluoroquinolone therapies of experimental gram-negative bacterial keratitis.
Topics: Animals; Anti-Infective Agents; Aza Compounds; Ciprofloxacin; Colony Count, Microbial; Cornea; Eye Infections, Bacterial; Fluoroquinolones; Keratitis; Levofloxacin; Microbial Sensitivity Tests; Moxifloxacin; Ofloxacin; Pseudomonas aeruginosa; Pseudomonas Infections; Quinolines; Rabbits; Serratia Infections; Serratia marcescens | 2004 |
Comparative efficacy of topical moxifloxacin versus ciprofloxacin and vancomycin in the treatment of P. aeruginosa and ciprofloxacin-resistant MRSA keratitis in rabbits.
Topics: Administration, Topical; Animals; Anti-Bacterial Agents; Aza Compounds; Ciprofloxacin; Colony Count, Microbial; Corneal Stroma; Drug Resistance, Multiple, Bacterial; Eye Infections, Bacterial; Fluoroquinolones; Keratitis; Methicillin Resistance; Moxifloxacin; Pseudomonas aeruginosa; Pseudomonas Infections; Quinolines; Rabbits; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 2005 |
Severe corneal toxicity after topical fluoroquinolone therapy: report of two cases.
Topics: Adult; Aged, 80 and over; Anti-Infective Agents; Aza Compounds; Corneal Edema; Corneal Transplantation; Corneal Ulcer; Diagnosis, Differential; Female; Fluoroquinolones; Follow-Up Studies; Glucocorticoids; Humans; Keratitis; Male; Moxifloxacin; Ophthalmic Solutions; Quinolines | 2006 |
Late-onset interface inflammation associated with wearing cosmetic lenses 18 months after laser in situ keratomileusis.
Topics: Adult; Aza Compounds; Contact Lenses; Corneal Edema; Drug Therapy, Combination; Female; Fluoroquinolones; Humans; Keratitis; Keratomileusis, Laser In Situ; Lasers, Excimer; Moxifloxacin; Myopia; Prednisolone; Quinolines; Surgical Flaps; Visual Acuity | 2008 |
Immunomodulatory effect of gatifloxacin on mouse peritoneal macrophages in vitro and in models of endotoxin-induced rat conjunctivitis and rabbit bacterial keratitis.
Topics: Animals; Anti-Inflammatory Agents; Aza Compounds; Cells, Cultured; Conjunctivitis; Endotoxins; Fluoroquinolones; Gatifloxacin; Immunologic Factors; Keratitis; Levofloxacin; Lipopolysaccharides; Macrophages, Peritoneal; Male; Methicillin Resistance; Mice; Mice, Inbred C3H; Moxifloxacin; Ofloxacin; Quinolines; Rabbits; Rats; Rats, Wistar; Staphylococcal Infections; Staphylococcus aureus; Tumor Necrosis Factor-alpha | 2008 |
Infectious keratitis secondary to Histoplasma capsulatum: the first case reports in humans.
Topics: Adult; Amphotericin B; Antifungal Agents; Aza Compounds; Eye Infections, Fungal; Fluoroquinolones; Histoplasma; Humans; Keratitis; Male; Moxifloxacin; Quinolines | 2007 |